Monocyte maturation, HIV susceptibility, and transmigration across the blood brain barrier are critical in HIV neuropathogenesis

Journal of Leukocyte Biology

Volumn 91, Issue 3, 2012, Pages 401-415

  Williams, Dionna W ^a   Eugenin, Eliseo A ^a   Calderon, Tina M ^a   Berman, Joan W ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Brain; CD; Dementia; HAND

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN;

BLOOD BRAIN BARRIER; CELL DIFFERENTIATION; CELL MATURATION; CELL POPULATION; CENTRAL NERVOUS SYSTEM; DIAPEDESIS; DISEASE COURSE; DISEASE PREDISPOSITION; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION SENSITIVITY; MONOCYTE; NERVOUS SYSTEM INFLAMMATION; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW;

ANIMALS; BLOOD-BRAIN BARRIER; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; ENCEPHALITIS, VIRAL; HIV INFECTIONS; HUMANS; IMMUNOPHENOTYPING; MACACA; MONOCYTES; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION;

EID: 84863289496     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0811394     Document Type: Review

References (209)

1. Graham, N. M. H., Zeger, S. L., Park, L. P., Vermund, S. H., Detels, R., Rinaldo, C. R., Phair, J. P. (1992) The effects on survival of early treatment of human immunodeficiency virus infection. N. Engl. J. Med. 326, 1037-1042.
2. Hammer, S. M., Squires, K. E., Hughes, M. D., Grimes, J. M., Demeter, L. M., Currier, J. S., Eron Jr., J. J., Feinberg, J. E., Balfour Jr., H. H., Deyton, L. R., Chodakewitz, J. A., Fischl, M. A. (1997) A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N. Engl. J. Med. 337, 725-733.
3. Li, T. S., Tubiana, R., Katlama, C., Calvez, V., Mohand, H. A., Autran, B. (1998) Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease. Lancet 351, 1682-1686.
4. Hunt, P. W., Deeks, S. G., Rodriguez, B., Valdez, H., Shade, S. B., Abrams, D. I., Kitahata, M. M., Krone, M., Neilands, T. B., Brand, R. J., Lederman, M. M., Martin, J. N. (2003) Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy. AIDS 17, 1907-1915.
5. Ances, B., Ellis, R. (2007) Dementia and neurocognitive disorders due to HIV-1 infection. Semin. Neurol. 27, 086-092.
6. Kaul, M., Zheng, J., Okamoto, S., Gendelman, H. E., Lipton, S. A. (2005) HIV-1 infection and AIDS: consequences for the central nervous system. Cell Death Differ. 12, 878-892.
7. Davis, L. E., Hjelle, B. L., Miller, V. E., Palmer, D. L., Llewellyn, A. L., Merlin, T. L., Young, S. A., Mills, R. G., Wachsman, W., Wiley, C. A. (1992) Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 42, 1736-1739.
8. Williams, K. C., Hickey, W. F. (2002) Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. Ann. Rev. Neurosci. 25, 537-562.
9. Antinori, A., Arendt, G., Becker, J. T., Brew, B. J., Byrd, D. A., Cherner, M., Clifford, D. B., Cinque, P., Epstein, L. G., Goodkin, K., Gisslen, M., Grant, I., Heaton, R. K., Joseph, J., Marder, K., Marra, C. M., McArthur, J. C., Nunn, M., Price, R. W., Pulliam, L., Robertson, K. R., Sacktor, N., Valcour, V., Wojna, V. E. (2007) Updated research nosology for HIVassociated neurocognitive disorders. Neurology 69, 1789-1799.
10. Cysique, L. A., Vaida, F., Letendre, S., Gibson, S., Cherner, M., Woods, S. P., McCutchan, J. A., Heaton, R. K., Ellis, R. J. (2009) Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy. Neurology 73, 342-348.
11. Sevigny, J. J., Albert, S. M., McDermott, M. P., McArthur, J. C., Sacktor, N., Conant, K., Schifitto, G., Selnes, O. A., Stern, Y., McClernon, D. R., Palumbo, D., Kieburtz, K., Riggs, G., Cohen, B., Epstein, L. G., Marder, K. (2004) Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia. Neurology 63, 2084-2090.
12. Nath, A., Schiess, N., Venkatesan, A., Rumbaugh, J., Sacktor, N., McArthur, J. (2008) Evolution of HIV dementia with HIV infection. Int. Rev. Psychiatry 20, 25-31.
13. Sacktor, N., McDermott, M. P., Marder, K., Schifitto, G., Selnes, O. A., Mcarthur, J. C., Stern, Y., Albert, S., Palumbo, D., Kieburtz, K., De Marcaida, J. A., Cohen, B., Epstein, L. (2002) HIV-associated cognitive impairment before and after the advent of combination therapy. J. Neurovirol. 8, 136-142.
14. Ances, B. M., Clifford, D. B. (2008) HIV-associated neurocognitive disorders and the impact of combination antiretroviral therapies. Curr. Neurol. Neurosci. Rep. 8, 455-461.
15. Ellis, R., Langford, D., Masliah, E. (2007) HIV and antiretroviral therapy in the brain: neuronal injury and repair. Nat. Rev. Neurosci. 8, 33-44.
16. Figdor, C., Bont, W., Touw, I., de Roos, J., Roosnek, E., de Vries, J. (1982) Isolation of functionally different human monocytes by counterflow centrifugation elutriation. Blood 60, 46-53.
17. Yasaka, T., Mantich, N., Boxer, L., Baehner, R. (1981) Functions of human monocyte and lymphocyte subsets obtained by countercurrent centrifugal elutriation: differing functional capacities of human monocyte subsets. J. Immunol. 127, 1515-1518.
18. Passlick, B., Flieger, D., Ziegler-Heitbrock, H. (1989) Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 74, 2527-2534.
19. Clarkson, S. B., Ory, P. A. (1988) CD16. Developmentally regulated IgG Fc receptors on cultured human monocytes. J. Exp. Med. 167, 408-420.
20. Ziegler-Heitbrock, L., Ancuta, P., Crowe, S., Dalod, M., Grau, V., Hart, D. N., Leenen, P. J. M., Liu, Y-J., MacPherson, G., Randolph, G. J., Scherberich, J., Schmitz, J., Shortman, K., Sozzani, S., Strobl, H., Zembala, M., Austyn, J. M., Lutz, M. B. (2010) Nomenclature of monocytes and dendritic cells in blood. Blood 116, e74-e80.
21. Tacke, F., Randolph, G. (2006) Migratory fate and differentiation of blood monocyte subsets. Immunobiology 211, 609-618.
22. Robbins, C. S., Swirski, F. K. (2010) The multiple roles of monocyte subsets in steady state and inflammation. Cell. Mol. Life Sci. 67, 2685-2693.
23. Ziegler-Heitbrock, H. W. L., Fingerle, G., Ströbel, M., Schraut, W., Stelter, F., Schütt, C., Passlick, B., Pforte, A. (1993) The novel subset of CD14+/CD16+ blood monocytes exhibits features of tissue macrophages. Eur. J. Immunol. 23, 2053-2058.
24. Thieblemont, N., Weiss, L., Sadeghi, H. M., Estcourt, C., Haeffner-Cavaillon, N. (1995) CD14lowCD16high: a cytokine-producing monocyte subset which expands during human immunodeficiency virus infection. Eur. J. Immunol. 25, 3418-3424.
25. Allen, J. B., Wong, H. L., Guyre, P. M., Simon, G. L., Wahl, S. M. (1991) Association of circulating receptor Fc γ RIII-positive monocytes in AIDS patients with elevated levels of transforming growth factor-β. J. Clin. Invest. 87, 1773-1779.
26. Pulliam, L., Gascon, R., Stubblebine, M., McGuire, D., McGrath, M. S. (1997) Unique monocyte subset in patients with AIDS dementia. Lancet 349, 692-695.
27. Fischer-Smith, T., Croul, S., Sverstiuk, A. E., Capini, C., L'Heureux, D., Regulier, E. G., Richardson, M. W., Amini, S., Morgello, S., Khalili, K., Rappaport, J. (2001) CNS invasion by CD14+/CD16+ peripheral bloodderived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection. J. Neurovirol. 7, 528-541.
28. Fischer-Smith, T., Croul, S., Adeniyi, A., Rybicka, K., Morgello, S., Khalili, K., Rappaport, J. (2004) Macrophage/microglial accumulation and proliferating cell nuclear antigen expression in the central nervous system in human immunodeficiency virus encephalopathy. Am. J. Pathol. 164, 2089-2099.
29. Clay, C. C., Rodrigues, D. S., Ho, Y. S., Fallert, B. A., Janatpour, K., Reinhart, T. A., Esser, U. (2007) Neuroinvasion of fluorescein-positive monocytes in acute simian immunodeficiency virus infection. J. Virol. 81, 12040-12048.
30. Buckner, C. M., Calderon, T. M., Willams, D. W., Belbin, T. J., Berman, J. W. (2011) Characterization of monocyte maturation/differentiation that facilitates their transmigration across the blood-brain barrier and infection by HIV: implications for NeuroAIDS. Cell. Immunol. 267, 109-123.
31. Van Furth, R., Cohn, Z. A. (1968) The origin and kinetics of mononuclear phagocytes. J. Exp. Med. 128, 415-435.
32. Haskill, S., Johnson, C., Eierman, D., Becker, S., Warren, K. (1988) Adherence induces selective mRNA expression of monocyte mediators and proto-oncogenes. J. Immunol. 140, 1690-1694.
33. Shaw, R. J., Doherty, D. E., Ritter, A. G., Benedict, S. H., Clark, R. A. (1990) Adherence-dependent increase in human monocyte PDGF(B) mRNA is associated with increases in c-fos, c-jun, and EGR2 mRNA. J. Cell. Biol. 111, 2139-2148.
34. Ziegler-Heitbrock, H. W. L. (1996) Heterogeneity of human blood monocytes: the CD14+CD16+ subpopulation. Immunol. Today 17, 424-428.
35. Kim, W-K., Sun, Y., Do, H., Autissier, P., Halpern, E. F., Piatak, M., Lifson, J. D., Burdo, T. H., McGrath, M. S., Williams, K. (2010) Monocyte heterogeneity underlying phenotypic changes in monocytes according to SIV disease stage. J. Leukoc. Biol. 87, 557-567.
36. Campbell, J. H., Burdo, T. H., Autissier, P., Bombardier, J. P., Westmoreland, S. V., Soulas, C., González, R. G., Ratai, E-M., Williams, K. C. (2011) Minocycline inhibition of monocyte activation correlates with neuronal protection in SIV NeuroAIDS. PLoS One 6, e18688.
37. Strauss-Ayali, D., Conrad, S. M., Mosser, D. M. (2007) Monocyte subpopulations and their differentiation patterns during infection. J. Leukoc. Biol. 82, 244-252.
38. Sánchez-Torres, C., García-Romo, G. S., Cornejo-Cortés, M. A., Rivas-Carvalho, A., Sánchez-Schmitz, G. (2001) CD16+ and CD16-human blood monocyte subsets differentiate in vitro to dendritic cells with different abilities to stimulate CD4+ T cells. Int. Immunol. 13, 1571-1581.
39. Gordon, S., Taylor, P. R. (2005) Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5, 953-964.
40. Ancuta, P., Liu, K-Y., Misra, V., Wacleche, V., Gosselin, A., Zhou, X., Gabuzda, D. (2009) Transcriptional profiling reveals developmental relationship and distinct biological functions of CD16+ and CD16-monocyte subsets. BMC Genomics 10, 403.
41. Imbert, A-M., Belaaloui, G., Bardin, F., Tonnelle, C., Lopez, M., Chabannon, C. (2006) CD99 expressed on human mobilized peripheral blood CD34+ cells is involved in transendothelial migration. Blood 108, 2578-2586.
42. Grage-Griebenow, E., Flad, H-D., Ernst, M. (2001) Heterogeneity of human peripheral blood monocyte subsets. J. Leukoc. Biol. 69, 11-20.
43. Stewart, M., Thiel, M., Hogg, N. (1995) Leukocyte integrins. Curr. Opin. Cell. Biol. 7, 690-696.
44. Todd, R. F., Petty, H. R. (1997) β2(CD11/CD18) Integrins can serve as signaling partners for other leukocyte receptors. J. Lab. Clin. Med. 129, 492-498.
45. Most, J., Schwaeble, W., Drach, J., Sommerauer, A., Dierich, M. (1992) Regulation of the expression of ICAM-1 on human monocytes and monocytic tumor cell lines. J. Immunol. 148, 1635-1642.
46. Zhang, W-Y., Schwartz, E., Wang, Y., Attrep, J., Li, Z., Reaven, P. (2006) Elevated concentrations of nonesterified fatty acids increase monocyte expression of CD11b and adhesion to endothelial cells. Arterioscler. Thromb. Vasc. Biol. 26, 514-519.
47. Lau, S. K., Chu, P. G., Weiss, L. M. (2004) CD163. Am. J. Clin. Pathol. 122, 794-801.
48. Nguyen, T. T., Schwartz, E. J., West, R. B., Warnke, R. A., Arber, D. A., Natkunam, Y. (2005) Expression of CD163 (hemoglobin scavenger receptor) in normal tissues, lymphomas, carcinomas, and sarcomas is largely restricted to the monocyte/macrophage lineage. Am. J. Surg. Pathol. 29, 617-624.
49. Roberts, E. S., Eleizeir, M., Howard, F. (2004) CD163 identifies a unique population of ramified microglia in HIV encephalitis (HIVE). J. Neuropathol. Exp. Neurol. 63, 1255-1264.
50. Fischer-Smith, T., Tedaldi, E. M., Rappaport, J. (2008) CD163/CD16 coexpression by circulating monocytes/macrophages in HIV: potential biomarkers for HIV infection and AIDS progression. AIDS Res. Hum. Retrovir. 24, 417-421.
51. Kim, W-K., Alvarez, X., Fisher, J., Bronfin, B., Westmoreland, S., McLaurin, J., Williams, K. (2006) CD163 identifies perivascular macrophages in normal and viral encephalitic brains and potential precursors to perivascular macrophages in blood. Am. J. Pathol. 168, 822-834.
52. Burdo, T. H., Soulas, C., Orzechowski, K., Button, J., Krishnan, A., Sugimoto, C., Alvarez, X., Kuroda, M. J., Williams, K. C. (2010) Increased monocyte turnover from bone marrow correlates with severity of SIV encephalitis and CD163 levels in plasma. PLoS Pathog. 6, e1000842.
53. Odink, K., Cerletti, N., Bruggen, J., Clerc, R. G., Tarcsay, L., Zwadlo, G., Gerhards, G., Schlegal, R., Sorg, C. (1987) Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis. Nature 330, 80-82.
54. Rugtveit, J., Brandtzaeg, P., Halstensen, T. S., Fausa, O., Scott, H. (1994) Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes. Gut 35, 669-674.
55. Brandtzaeg, P., Flavell, D. J., Fagerhol, M. K. (1988) Mac 387 antibody and detection of formalin resistant myelomonocytic L1 antigen. J. Clin. Pathol. 41, 963-970.
56. Otani, I., Mori, K., Sata, T., Terao, K., Doi, K., Akari, H., Yoshikawa, Y. (1999) Accumulation of MAC387+ macrophages in paracortical areas of lymph nodes in rhesus monkeys acutely infected with simian immunodeficiency virus. Microb. Infect. 1, 977-985.
57. Soulas, C., Conerly, C., Kim, W-K., Burdo, T. H., Alvarez, X., Lackner, A. A., Williams, K. C. (2011) Recently infiltrating MAC387+ monocytes/ macrophages. Am. J. Pathol. 178, 2121-2135.
58. Mouillet-Richard, S., Ermonval, M., Chebassier, C., Laplanch, J. L., Lehmann, S., Launay, J. M., Kellermann, O. (2000) Signal transduction through prion protein. Science 289, 1925-1928.
59. Schneider, B., Mutel, V., Pietri, M., Ermonval, M., Mouillet-Richard, S., Kellermann, O. (2003) NADPH oxidase and extracellular regulated kinases 1/2 are targets of prion protein signaling in neuronal and nonneuronal cells. Proc. Natl. Acad. Sci. USA 100, 13326-13331.
60. Moser, M., Colello, R. J., Pott, U., Oesch, B. (1995) Developmental expression of the prion protein gene in glial cells. Neuron 14, 509-517.
61. Jeffrey, M., Goodsir, C. M., Race, R. E., Chesebro, B. (2004) Scrapiespecific neuronal lesions are independent of neuronal PrP expression. Ann. Neurol. 55, 781-792.
62. Viegas, P., Chaverot, N., Enslen, H., Perrière, N., Couraud, P-O., Cazaubon, S. (2006) Junctional expression of the prion protein PrPC by brain endothelial cells: a role in trans-endothelial migration of human monocytes. J. Cell Sci. 119, 4634-4643.
63. Roberts, T. K., Eugenin, E. A., Morgello, S., Clements, J. E., Zink, M. C., Berman, J. W. (2010) PrPC, the cellular isoform of the human prion protein, is a novel biomarker of HIV-associated neurocognitive impairment and mediates neuroinflammation. Am. J. Pathol. 177, 1848-1860.
64. Geissmann, F., Jung, S., Littman, D. R. (2003) Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19, 71-82.
65. Merino, A., Buendia, P., Martin-Malo, A., Aljama, P., Ramirez, R., Carracedo, J. (2011) Senescent CD14+CD16+ monocytes exhibit proinflammatory and proatherosclerotic activity. J. Immunol. 186, 1809-1815.
66. Ancuta, P., Rao, R., Moses, A., Mehle, A., Shaw, S. K., Luscinskas, F. W., Gabuzda, D. (2003) Fractalkine preferentially mediates arrest and migration of CD16+ monocytes. J. Exp. Med. 197, 1701-1707.
67. Weber, C., Belge, K., von Hundelshausen, P., Draude, G., Steppich, B., Mack, M., Frankenberger, M., Weber, K., Ziegler-Heitbrock, H. (2000) Differential chemokine receptor expression and function in human monocyte subpopulations. J. Leukoc. Biol. 67, 699-704.
68. Muller, W. A. (2003) Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response. Trends Immunol. 24, 327-334.
69. Ley, K., Laudanna, C., Cybulsky, M. I., Nourshargh, S. (2007) Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7, 678-689.
70. Millan, J., Hewlett, L., Glyn, M., Toomre, D., Clark, P., Ridley, A. J. (2006) Lymphocyte transcellular migration occurs through recruitment of endothelial ICAM-1 to caveola-and F-actin-rich domains. Nat. Cell Biol. 8, 113-123.
71. Muller, W. A. (2011) Mechanisms of leukocyte transendothelial migration. Ann. Rev. Pathol. Mech. Dis. 6, 323-344.
72. Eugenin, E. A., Berman, J. W. (2003) Chemokine-dependent mechanisms of leukocyte trafficking across a model of the blood-brain barrier. Methods 29, 351-361.
73. Eugenin, E. A., Osiecki, K., Lopez, L., Goldstein, H., Calderon, T. M., Berman, J. W. (2006) CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS. J. Neurosci. 26, 1098-1106.
74. Janzer, R. C., Raff, M. C. (1987) Astrocytes induce blood-brain barrier properties in endothelial cells. Nature 325, 253-257.
75. Abbott, N. J., Ronnback, L., Hansson, E. (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 7, 41-53.
76. Gloor, S. M., Wachtel, M., Bolliger, M. F., Ishihara, H., Landmann, R., Frei, K. (2001) Molecular and cellular permeability control at the bloodbrain barrier. Brain Res. Brain Res. Rev. 36, 258-264.
77. Hickey, W. F., Hsu, B. L., Kimura, H. (1991) T-lymphocyte entry into the central nervous system. J. Neurosci. Res. 28, 254-260.
78. Hickey, W. F. (1999) Leukocyte traffic in the central nervous system: the participants and their roles. Semin. Immunol. 11, 125-137.
79. Greenwood, J., Heasman, S. J., Alvarez, J. I., Prat, A., Lyck, R., Engelhardt, B. (2011) Review: leucocyte-endothelial cell crosstalk at the blood-brain barrier: a prerequisite for successful immune cell entry to the brain. Neuropathol. Appl. Neurobiol. 37, 24-39.
80. Masedunskas, A., King, J. A., Tan, F., Cochran, R., Stevens, T., Sviridov, D., Ofori-Acquah, S. F. (2006) Activated leukocyte cell adhesion molecule is a component of the endothelial junction involved in transendothelial monocyte migration. FEBS Lett. 580, 2637-2645.
81. Cayrol, R., Wosik, K., Berard, J. L., Dodelet-Devillers, A., Ifergan, I., Kebir, H., Haqqani, A. S., Kreymborg, K., Krug, S., Moumdjian, R., Bouthillier, A., Becher, B., Arbour, N., David, S., Stanimirovic, D., Prat, A. (2008) Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system. Nat. Immunol. 9, 137-145.
82. Rauch, S. J., Rosenkranz, A. C., Böhm, A., Meyer-Kirchrath, J., Hohlfeld, T., Schrör, K., Rauch, B. H. Cholesterol induces apoptosis-associated loss of the activated leukocyte cell adhesion molecule (ALCAM) in human monocytes. Vasc. Pharmacol. 54, 93-99.
83. Gimferrer, I., Calvo, M., Mittelbrunn, M., Farnós, M., Sarrias, M. R., Enrich, C., Vives, J., Sánchez-Madrid, F., Lozano, F. (2004) Relevance of CD6-mediated interactions in T cell activation and proliferation. J. Immunol. 173, 2262-2270.
84. Zimmerman, A. W., Joosten, B., Torensma, R., Parnes, J. R., van Leeuwen, F. N., Figdor, C. G. (2006) Long-term engagement of CD6 and ALCAM is essential for T-cell proliferation induced by dendritic cells. Blood 107, 3212-3220.
85. Yao, H., Kim, K., Duan, M., Hayashi, T., Guo, M., Morgello, S., Prat, A., Wang, J., Su, T-P., Buch, S. (2011) Cocaine hijacks ω1 receptor to initiate induction of activated leukocyte cell adhesion molecule: implication for increased monocyte adhesion and migration in the CNS. J. Neurosci. 31, 5942-5955.
86. Bouwman, F. H., Skolasky, R. L., Hes, D., Selnes, O. A., Glass, J. D., Nance-Sproson, T. E., Royal, W., Dal Pan, G. J., McArthur, J. C. (1998) Variable progression of HIV[b]-associated dementia. Neurology 50, 1814-1820.
87. Dhillon, N. K., Peng, F., Bokhari, S., Callen, S., Shin, S.-H., Zhu, H., Kim, K., Buch, S. J. (2008) Cocaine-mediated alteration in tight junction protein expression and modulation of CCL2/CCR2 axis across the blood-brain barrier: implications for HIV-dementia. J. Neuroimmune Pharmacol. 3, 52-56.
88. Kapadia, F., Vlahov, D., Donahue, R. M., Friedland, G. (2005) The role of substance abuse in HIV disease progression: reconciling differences from laboratory and epidemiologic investigations. Clin. Infect. Dis. 41, 1027-1034.
89. Mahajan, S. D., Aalinkeel, R., Sykes, D. E., Reynolds, J. L., Bindukumar, B., Adal, A., Qi, M., Toh, J., Xu, G., Prasad, P. N., Schwartz, S. A. (2008) Methamphetamine alters blood brain barrier permeability via the modulation of tight junction expression: implication for HIV-1 neuropathogenesis in the context of drug abuse. Brain Res. 1203, 133-148.
90. Shapshak, P., Kangueane, P., Fujimura, R. K., Commins, D., Chiappelli, F., Singer, E., Levine, A. J., Minagar, A., Novembre, F. J., Somboonwit, C., Nath, A., Sinnott, J. T. (2011) Editorial NeuroAIDS review. AIDS 25, 123-141.
91. Weber, C., Fraemohs, L., Dejana, E. (2007) The role of junctional adhesion molecules in vascular inflammation. Nat. Rev. Immunol. 7, 467-477.
92. Martìn-Padura, I., Lostaglio, S., Schneemann, M., Williams, L., Romano, M., Fruscella, P., Panzeri, C., Stoppacciaro, A., Ruco, L., Villa, A., Simmons, D., Dejana, E. (1998) Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J. Cell Biol. 142, 117-127.
93. Del Maschio, A., De Luigi, A., Martin-Padura, I., Brockhaus, M., Bartfai, T., Fruscella, P., Adorini, L., Martino, G., Furlan, R., De Simoni, M. G., Dejana, E. (1999) Leukocyte recruitment in the cerebrospinal fluid of mice with experimental meningitis Is inhibited by an antibody to junctional adhesion molecule (Jam). J. Exp. Med. 190, 1351-1356.
94. Zernecke, A., Liehn, E. A., Fraemohs, L., von Hundelshausen, P., Koenen, R. R., Corada, M., Dejana, E., Weber, C. (2006) Importance of junctional adhesion molecule-A for neointimal lesion formation and infiltration in atherosclerosis-prone mice. Arterioscl. Thromb. Vasc. Biol. 26, e10-e13.
95. Ostermann, G., Weber, K. S. C., Zernecke, A., Schroder, A., Weber, C. (2002) JAM-1 is a ligand of the β2 integrin LFA-1 involved in transendothelial migration of leukocytes. Nat. Immunol. 3, 151-158.
96. Woodfin, A., Reichel, C. A., Khandoga, A., Corada, M., Voisin, M. B., Scheiermann, C., Haskard, D. O., Dejana, E., Krombach, F., Nourshargh, S. (2007) JAM-A mediates neutrophil transmigration in a stimulus-specific manner in vivo: evidence for sequential roles for JAM-A and PECAM-1 in neutrophil transmigration. Blood 110, 1848-1856.
97. Khandoga, A., Kessler, J. S., Meissner, H., Hanschen, M., Corada, M., Motoike, T., Enders, G., Dejana, E., Krombach, F. (2005) Junctional adhesion molecule-A deficiency increases hepatic ischemia-reperfusion injury despite reduction of neutrophil transendothelial migration. Blood 106, 725-733.
98. Corada, M., Chimenti, S., Cera, M. R., Vinci, M., Salio, M., Fiordaliso, F., De Angelis, N., Villa, A., Bossi, M., Staszewsky, L. I., Vecchi, A., Parazzoli, D., Motoike, T., Latini, R., Dejana, E. (2005) Junctional adhesion molecule-A-deficient polymorphonuclear cells show reduced diapedesis in peritonitis and heart ischemia-reperfusion injury. Proc. Natl. Acad. Sci. USA 102, 10634-10639.
99. Lechner, F., Sahrbacher, U., Suter, T., Frei, K., Brockhaus, M., Koedel, U., Fontana, A. (2000) Antibodies to the junctional adhesion molecule cause disruption of endothelial cells and do not prevent leukocyte influx into the meninges after viral or bacterial infection. J. Infect. Dis. 182, 978-982.
100. Liu, Y., Nusrat, A., Schnell, F., Reaves, T., Walsh, S., Pochet, M., Parkos, C. (2000) Human junction adhesion molecule regulates tight junction resealing in epithelia. J. Cell Sci. 113, 2363-2374.
101. Shaw, S. K., Ma, S., Kim, M. B., Rao, R. M., Hartman, C. U., Froio, R. M., Yang, L., Jones, T., Liu, Y., Nusrat, A., Parkos, C. A., Luscinskas, F. W. (2004) Coordinated redistribution of leukocyte LFA-1 and endothelial cell ICAM-1 accompany neutrophil transmigration. J. Exp. Med. 200, 1571-1580.
102. Schenkel, A. R., Mamdouh, Z., Muller, W. A. (2004) Locomotion of monocytes on endothelium is a critical step during extravasation. Nat. Immunol. 5, 393-400.
103. Nourshargh, S., Krombach, F., Dejana, E. (2006) The role of JAM-A and PECAM-1 in modulating leukocyte infiltration in inflamed and ischemic tissues. J. Leukoc. Biol. 80, 714-718.
104. Imhof, B. A., Aurrand-Lions, M. (2004) Adhesion mechanisms regulating the migration of monocytes. Nat. Rev. Immunol. 4, 432-444.
105. Muller, W. A., Weigl, S. A., Deng, X., Phillips, D. M. (1993) PECAM-1 is required for transendothelial migration of leukocytes. J. Exp. Med. 178, 449-460.
106. Vaporciyan, A., DeLisser, H. M., Yan, H., Mendiguren, I. I., Thorn, S. R., Jones, M. L., Ward, P. A., Albelda, S. M. (1993) Involvement of platelet-endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo. Science 262, 1580-1582.
107. Schenkel, A. R., Chew, T. W., Muller, W. A. (2004) Platelet endothelial cell adhesion molecule deficiency or blockade significantly reduces leukocyte emigration in a majority of mouse strains. J. Immunol. 173, 6403-6408.
108. Dasgupta, B., Dufour, E., Mamdouh, Z., Muller, W. A. (2009) A novel and critical role for tyrosine 663 in platelet endothelial cell adhesion molecule-1 trafficking and transendothelial migration. J. Immunol. 182, 5041-5051.
109. Roberts, T. K., Buckner, C. M., Berman, J. W. (2010) Leukocyte transmigration across the blood-brain barrier: perspectives on neuroAIDS. Front. Biosci. 15, 478-536.
110. Graesser, D., Solowiej, A., Bruckner, M., Osterweill, E., Juedes, A., Davis, S., Ruddle, N. H., Engelhardt, B., Madri, J. A. (2002) Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice. J. Clin. Invest. 109, 383-392.
111. Liao, F., Huynh, H. K., Eiroa, A., Greene, T., Polizzi, E., Muller, W. A. (1995) Migration of monocytes across endothelium and passage through extracellular matrix involve separate molecular domains of PECAM-1. J. Exp. Med. 182, 1337-1343.
112. Eugenin, E. A., Gamss, R., Buckner, C., Buono, D., Klein, R. S., Schoenbaum, E. E., Calderon, T. M., Berman, J. W. (2006) Shedding of PECAM-1 during HIV infection: a potential role for soluble PECAM-1 in the pathogenesis of NeuroAIDS. J. Leukoc. Biol. 79, 444-452.
113. Suh, Y. H., Shin, Y. K., Kook, M., Oh, K. I., Park, W. S., Kim, S. H., Lee, I.-S., Park, H. J., Huh, T., Park, S. H. (2003) Cloning, genomic organization, alternative transcripts and expression analysis of CD99L2, a novel paralog of human CD99, and identification of evolutionary conserved motifs. Gene 307, 63-76.
114. Lou, O., Alcaide, P., Luscinskas, F. W., Muller, W. A. (2007) CD99 is a key mediator of the transendothelial migration of neutrophils. J. Immunol. 178, 1136-1143.
115. Schenkel, A. R., Mamdouh, Z., Chen, X., Liebman, R. M., Muller, W. A. (2002) CD99 plays a major role in the migration of monocytes through endothelial junctions. Nat. Immunol. 3, 143-150.
116. Bixel, G., Kloep, S., Butz, S., Petri, B., Engelhardt, B., Vestweber, D. (2004) Mouse CD99 participates in T-cell recruitment into inflamed skin. Blood 104, 3205-3213.
117. Dufour, E. M., Deroche, A., Bae, Y. M., Muller, W. A. (2008) CD99 Is essential for leukocyte diapedesis in vivo. Cell Commun. Adhes. 15, 351-363.
118. Bixel, M. G., Li, H., Petri, B., Khandoga, A. G., Khandoga, A., Zarbock, A., Wolburg-Buchholz, K., Wolburg, H., Sorokin, L., Zeuschner, D., Maerz, S., Butz, S., Krombach, F., Vestweber, D. (2010) CD99 and CD99L2 act at the same site as, but independently of, PECAM-1 during leukocyte diapedesis. Blood 116, 1172-1184.
119. Bixel, M. G., Petri, B., Khandoga, A. G., Khandoga, A., Wolburg-Buchholz, K., Wolburg, H., März, S., Krombach, F., Vestweber, D. (2007) A CD99-related antigen on endothelial cells mediates neutrophil but not lymphocyte extravasation in vivo. Blood 109, 5327-5336.
120. Nakamuta, S., Endo, H., Higashi, Y., Kousaka, A., Yamada, H., Yano, M., Kido, H. (2008) Human immunodeficiency virus type 1 gp120-mediated disruption of tight junction proteins by induction of proteasomemediated degradation of zonula occludens-1 and-2 in human brain microvascular endothelial cells. J. Neurovirol. 14, 186-195.
121. King, J. E., Eugenin, E. A., Buckner, C. M., Berman, J. W. (2006) HIV tat and neurotoxicity. Microbes Infect. 8, 1347-1357.
122. Kanmogne, G. D., Schall, K., Leibhart, J., Knipe, B., Gendelman, H. E., Persidsky, Y. (2006) HIV-1 gp120 compromises blood-brain barrier integrity and enhance monocyte migration across blood-brain barrier: implication for viral neuropathogenesis. J. Cereb. Blood Flow Metab. 27, 123-134.
123. Alexander, J. S., Dayton, T., Davis, C., Hill, S., Jackson, T. H., Blaschuk, O., Symonds, M., Okayama, N., Kevil, C. G., Laroux, F. S., Berney, S. M., Kimpel, D. (1998) Activated T-lymphocytes express occludin, a component of tight junctions. Inflammation 22, 573-582.
124. Bethel-Brown, C., Yao, H., Callen, S., Lee, Y. H., Dash, P. K., Kumar, A., Buch, S. (2011) HIV-1 tat-mediated induction of platelet-derived growth factor in astrocytes: role of early growth response gene 1. J. Immunol. 186, 4119-4129.
125. Weiss, J. M., Downie, S. A., Lyman, W. D., Berman, J. W. (1998) Astrocyte-derived monocyte-chemoattractant protein-1 directs the transmigration of leukocytes across a model of the human blood-brain barrier. J. Immunol. 161, 6896-6903.
126. Weiss, J. M., Nath, A., Major, E. O., Berman, J. W. (1999) HIV-1 tat induces monocyte chemoattractant protein-1-mediated monocyte transmigration across a model of the human bood-brain barrier and up-regulates CCR5 expression on human monocytes. J. Immunol. 163, 2953-2959.
127. Eugenin, E. A., Clements, J. E., Zink, M. C., Berman, J. W. (2011) Human immunodeficiency virus infection of human astrocytes disrupts blood-brain barrier integrity by a gap junction-dependent mechanism. J. Neurosci. 31, 9456-9465.
128. Cinque, P., Vago, L., Mengozzi, M., Torri, V., Ceresa, D., Vicenzi, E., Transidico, P., Vagani, A., Sozzani, S., Mantovani, A., Lazzarin, A., Poli, G. (1998) Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication. AIDS 12, 1327-1332.
129. Conant, K., Garzino-Demo, A., Nath, A., McArthur, J. C., Halliday, W., Power, C., Gallo, R. C., Major, E. O. (1998) Induction of monocyte chemoattractant protein-1 in HIV-1 tat-stimulated astrocytes and elevation in AIDS dementia. Proc. Natl. Acad. Sci. USA 95, 3117-3121.
130. Kelder, W., McArthur, J. C., Nance-Sproson, T. E., McClernon, D. R., Griffin, D. E. (1998) B-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia. Ann. Neurol. 44, 831-835.
131. Tong, N., Perry, S. W., Zhang, Q., James, H. J., Guo, H., Brooks, A., Bal, H., Kinnear, S. A., Fine, S., Epstein, L. G., Dairaghi, D., Schall, T. J., Gendelman, H. E., Dewhurst, S., Sharer, L. R., Gelbard, H. A. (2000) Neuronal fractalkine expression in HIV-1 encephalitis: roles for macrophage recruitment and neuroprotection in the central nervous system. J. Immunol. 164, 1333-1339.
132. Cotter, R., Williams, C., Ryan, L., Erichsen, D., Lopez, A., Peng, H., Zheng, J. (2002) Fractalkine (CX3CL1) and brain inflammation: implications for HIV-1-associated dementia. J. Neurovirol. 8, 585-598.
133. Ancuta, P., Wang, J., Gabuzda, D. (2006) CD16+ monocytes produce IL-6, CCL2, and matrix metalloproteinase-9 upon interaction with CX3CL1-expressing endothelial cells. J. Leukoc. Biol. 80, 1156-1164.
134. Ho, D. D., Rota, T. R., Hirsch, M. S. (1986) Infection of monocyte/macrophages by human T lymphotropic virus type III. J. Clin. Invest. 77, 1712-1715.
135. Wu, Y. (2004) HIV-1 gene expression: lessons from provirus and nonintegrated DNA. Retrovirology 1, 1-10.
136. Eugenin, E. A., Berman, J. W. (2007) Gap junctions mediate human immunodeficiency virus-bystander killing in astrocytes. J. Neurosci. 27, 12844-12850.
137. Brack-Werner, R. (1999) Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis. AIDS 13, 1-22.
138. Kaul, M., Garden, G. A., Lipton, S. A. (2001) Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410, 988-994.
139. Verani, A., Pesenti, E., Polo, S., Tresoldi, E., Scarlatti, G., Lusso, P., Siccardi, A. G., Vercelli, D. (1998) Cutting edge: CXCR4 is a functional coreceptor for infection of human macrophages by CXCR4-dependent primary HIV-1 Isolates. J. Immunol. 161, 2084-2088.
140. Samson, M., Libert, F., Doranz, B. J., Rucker, J., Liesnardt, C., Farber, C., Saragosti, S., Lapoumeroulie, C., Cognaux, J., Forceille, C., Muyldermans, G., Verhofstede, C., Burtonboy, G., Georges, M., Imai, T., Rana, S., Yi, Y., Smyth, R. J., Collman, R. G., Doms, R. W., Vassart, G., Parmentier, M. (1996) Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382, 722-725.
141. Liu, R., Paxton, W. A., Choe, S., Ceradini, D., Martin, S. R., Horuk, R., MacDonald, M. E., Stuhlmann, H., Koup, R. A., Landau, N. R. (1996) Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86, 367-377.
142. McElrath, M. J., Pruett, J. E., Cohn, Z. A. (1989) Mononuclear phagocytes of blood and bone marrow: comparative roles as viral reservoirs in human immunodeficiency virus type 1 infections. Proc. Natl. Acad. Sci. USA 86, 675-679.
143. Coleman, C. M., Wu, L. (2009) HIV interactions with monocytes and dendritic cells: viral latency and reservoirs. Retrovirology 6, 51.
144. Arfi, V., Riviere, L., Jarrosson-Wuilleme, L., Goujon, C., Rigal, D., Darlix, J. L., Cimarelli, A. (2008) Characterization of the early steps of infection of primary blood monocytes by human immunodeficiency virus type 1. J. Virol. 82, 6557-6565.
145. Weinberg, J. B., Matthews, T. J., Cullen, B. R., Malim, M. H. (1991) Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes. J. Exp. Med. 174, 1477-1482.
146. Bergamaschi, A., Pancino, G. (2010) Host hindrance to HIV-1 replication in monocytes and macrophages. Retrovirology 7, 31.
147. Sonza, S., Mutimer, H. P., Oelrichs, R., Jardine, D., Harvey, K., Dunne, A., Purcell, D. F., Birch, C., Crowe, S. M. (2001) Monocytes harbour replication-competent, non-latent HIV-1 in patients on highly active antiretroviral therapy. AIDS 15, 17-22.
148. Zhu, T., Muthui, D., Holte, S., Nickle, D., Feng, F., Brodie, S., Hwangbo, Y., Mullins, J. I., Corey, L. (2002) Evidence for human immunodeficiency virus type 1 replication in vivo in CD14 monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy. J. Virol. 76, 707-716.
149. Furtado, M. R., Callaway, D. S., Phair, J. P., Kunstman, K. J., Stanton, J. L., Macken, C. A., Perelson, A. S., Wolinsky, S. M. (1999) Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy. N. Engl. J. Med. 340, 1614-1622.
150. Crowe, S. M., Sonza, S. (2000) HIV-1 can be recovered from a variety of cells including peripheral blood monocytes of patients receiving highly active antiretroviral therapy: a further obstacle to eradication. J. Leukoc. Biol. 68, 345-350.
151. Valcour, V. G., Shiramizu, B. T., Sithinamsuwan, P., Nidhinandana, S., Ratto-Kim, S., Ananworanich, J., Siangphoe, U., Kim, J. H., de Souza, M., Degruttola, V., Paul, R. H., Shikuma, C. M. (2009) HIV DNA and cognition in a Thai longitudinal HAART initiation cohort: the SEARCH 001 Cohort Study. Neurology 72, 992-998.
152. Lambotte, O., Taoufik, Y., de Goer, M. G., Wallon, C., Goujard, C., Delfraissy, J. F. (2000) Detection of infectious HIV in circulating monocytes from patients on prolonged highly active antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 23, 114-119.
153. Llewellyn, N., Zioni, R., Zhu, H., Andrus, T., Xu, Y., Corey, L., Zhu, T. (2006) Continued evolution of HIV-1 circulating in blood monocytes with antiretroviral therapy: genetic analysis of HIV-1 in monocytes and CD4+ T cells of patients with discontinued therapy. J. Leukoc. Biol. 80, 1118-1126.
154. Patterson, B. K., Mosiman, V. L., Cantarero, L., Furtado, M., Bhattacharya, M., Goolsby, C. (1998) Detection of HIV-RNA-positive monocytes in peripheral blood of HIV-positive patients by simultaneous flow cytometric analysis of intracellular HIV RNA and cellular immunophenotype. Cytometry 31, 265-274.
155. Saksela, K., Stevens, C., Rubinstein, P., Baltimore, D. (1994) Human immunodeficiency virus type 1 mRNA expression in peripheral blood cells predicts disease progression independently of the numbers of CD4+ lymphocytes. Proc. Natl. Acad. Sci. USA 91, 1104-1108.
156. Ancuta, P., Kunstman, K., Autissier, P., Zaman, T., Stone, D., Wolinsky, S., Gabuzda, D. (2006) CD16+ monocytes exposed to HIV promote highly efficient viral replication upon differentiation into macrophages and interaction with T cells. Virology 344, 267-276.
157. Ellery, P. J., Tippett, E., Chiu, Y. L., Paukovics, G., Cameron, P. U., Solomon, A., Lewin, S. R., Gorry, P. R., Jaworowski, A., Greene, W. C., Sonza, S., Crowe, S. M. (2007) The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo. J. Immunol. 178, 6581-6589.
158. Han, J., Wang, B., Han, N., Zhao, Y., Song, C., Feng, X., Mao, Y., Zhang, F., Zhao, H., Zeng, H. (2009) CD14(high)CD16(+) rather than CD14(low)CD16(+) monocytes correlate with disease progression in chronic HIV-infected patients. J. Acquir. Immune Defic. Syndr. 52, 553-559.
159. Pulliam, L., Sun, B., Rempel, H. (2004) Invasive chronic inflammatory monocyte phenotype in subjects with high HIV-1 viral load. J. Neuroimmunol. 157, 93-98.
160. Sonza, S., Maerz, A., Deacon, N., Meanger, J., Mills, J., Crowe, S. (1996) Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes. J. Virol. 70, 3863-3869.
161. Eisert, V., Kreutz, M., Becker, K., Königs, C., Alex, U., Rübsamen-Waigmann, H., Andreesen, R., von Briesen, H. (2001) Analysis of cellular factors influencing the replication of human immunodeficiency virus type I in human macrophages derived from blood of different healthy donors. Virology 286, 31-44.
162. O'Brien, W. A., Namazi, A., Kalhor, H., Mao, S.-H., Zack, J. A., Chen, I. S. Y. (1994) Kinetics of human immunodeficiency virus type 1 reverse transcription in blood mononuclear phagocytes are slowed by limitations of nucleotide precursors. J. Virol. 68, 1258-1263.
163. Srichatrapimuk, S., Auewarakul, P. (2007) Resistance of monocyte to HIV-1 infection is not due to uncoating defect. Virus Res. 126, 277-281.
164. Triques, K., Stevenson, M. (2004) Characterization of restrictions to human immunodeficiency virus type 1 infection of monocytes. J. Virol. 78, 5523-5527.
165. Naif, H. M., Li, S., Alali, M., Sloane, A., Wu, L., Kelly, M., Lynch, G., Lloyd, A., Cunningham, A. L. (1998) CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection. J. Virol. 72, 830-836.
166. Tuttle, D. L., Harrison, J. K., Anders, C., Sleasman, J. W., Goodenow, M. M. (1998) Expression of CCR5 increases during monocyte differentiation and directly mediates macrophage susceptibility to infection by human immunodeficiency virus type 1. J. Virol. 72, 4962-4969.
167. Wang, X., Ye, L., Hou, W., Zhou, Y., Wang, Y. J., Metzger, D. S., Ho, W. Z. (2009) Cellular microRNA expression correlates with susceptibility of monocytes/macrophages to HIV-1 infection. Blood 113, 671-674.
168. Sung, T. L., Rice, A. P. (2009) miR-198 inhibits HIV-1 gene expression and replication in monocytes and its mechanism of action appears to involve repression of cyclin T1. PLoS Pathog. 5, e1000263.
169. Peng, G., Greenwell-Wild, T., Nares, S., Jin, W., Lei, K. J., Rangel, Z. G., Munson, P. J., Wahl, S. M. (2007) Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression. Blood 110, 393-400.
170. Stremlau, M., Owens, C. M., Perron, M. J., Kiessling, M., Autissier, P., Sodroski, J. (2004) The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys. Nature 427, 848-853.
171. Kraft-Terry, S. D., Stothert, A. R., Buch, S., Gendelman, H. E. (2010) HIV-1 neuroimmunity in the era of antiretroviral therapy. Neurobiol. Dis. 37, 542-548.
172. Langford, T. D., Letendre, S. L., Larrea, G. J., Masliah, E. (2003) Changing patterns in the neuropathogenesis of HIV during the HAART Era. Brain Pathol. 13, 195-210.
173. Yadav, A., Collman, R. G. (2009) CNS inflammation and macrophage/ microglial biology associated with HIV-1 infection. J. Neuroimmune Pharmacol. 4, 430-447.
174. Zheng, J., Gendelman, H. E. (1997) The HIV-1 associated dementia complex: a metabolic encephalopathy fueled by viral replication in mononuclear phagocytes. Curr. Opin. Neurol. 10, 319-326.
175. Liner, K., Ro, M., Robertson, K. (2010) HIV, antiretroviral therapies, and the brain. Curr. HIV/AIDS Rep. 7, 85-91.
176. Harezlak, J., Buchthal, S., Taylor, M., Schifitto, G., Zhong, J., Daar, E., Alger, J., Singer, E., Campbell, T., Yiannoutsos, C., Cohen, R., Navia, B., HIV Neuroimaging Consortium (2011) Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment. AIDS 25, 625-633.
177. Edén, A., Price, Richard W., Spudich, S., Fuchs, D., Hagberg, L., Gisslén, M. (2007) Immune activation of the central nervous system is still present after >4 years of effective highly active antiretroviral therapy. J. Infect. Dis. 196, 1779-1783.
178. Gannon, P., Khan, M. Z., Kolson, D. L. (2011) Current understanding of HIV-associated neurocognitive disorders pathogenesis. Curr. Opin. Neurol. 24, 275-283.
179. Anthony, I. C., Ramage, S. N., Carnie, F. W., Simmonds, P., Bell, J. E. (2005) Influence of HAART on HIV-related CNS disease and neuroinflammation. J. Neuropathol. Exp. Neurol. 64, 529-536.
180. Everall, I., Vaida, F., Khanlou, N., Lazzaretto, D., Achim, C., Letendre, S., Moore, D., Ellis, R., Cherner, M., Gelman, B., Morgello, S., Singer, E., Grant, I., Masliah, E. (2009) Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy. J. Neurovirol. 15, 360-370.
181. Anthony, I. C., Bell, P. J. E. (2008) The neuropathology of HIV/AIDS. Int. Rev. Psychiatry 20, 15-24.
182. Simioni, S., Cavassini, M., Annoni, J-M., Hirschel, B., Du Pasquier, R. A. (2010) HIV-associated neurocognitive disorders: a changing pattern. Future Neurol. 6, 81-95.
183. Heaton, R., Franklin, D., Ellis, R., McCutchan, J., Letendre, S., LeBlanc, S., Corkran, S., Duarte, N., Clifford, D., Woods, S., Collier, A., Marra, C., Morgello, S., Mindt, M., Taylor, M., Marcotte, T., Atkinson, J., Wolfson, T., Gelman, B., McArthur, J., Simpson, D., Abramson, I., Gamst, A., Fennema-Notestine, C., Jernigan, T., Wong, J., Grant, I., Charter, f. t., Groups, H. (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J. Neurovirol. 17, 3-16.
184. Shiramizu, B., Paul, R., Williams, A., Shikuma, C., Watters, M., Grove, J., Valcour, V. (2007) HIV proviral DNA associated with decreased neuropsychological function. J. Neuropsychiatry Clin. Neurosci. 19, 157-163.
185. Valcour, V. G., Shiramizu, B. T., Shikuma, C. M. (2010) HIV DNA in circulating monocytes as a mechanism to dementia and other HIV complications. J. Leukoc. Biol. 87, 621-626.
186. Lopez, C., Vazquez, M., Hill, M., Del, C. Colon, M., Porrata-Doria, T., Johnston, I., Lorenzo, E. (2010) Characterization of HIV-1 RNA forms in the plasma of patients undergoing successful HAART. Arch. Virol. 155, 895-903.
187. Lu, S-M., Tremblay, M-É., King, I. L., Qi, J., Reynolds, H. M., Marker, D. F., Varrone, J. J. P., Majewska, A. K., Dewhurst, S., Gelbard, H. A. (2011) HIV-1 tat-induced microgliosis and synaptic damage via interactions between peripheral and central myeloid cells. PLoS One 6, e23915.
188. McPhail, M., Robertson, K. (2011) Neurocognitive impact of antiretroviral treatment: thinking long-term. Curr. HIV/AIDS Rep. 8, 249-256.
189. Schouten, J., Cinque, P., Gisslen, M., Reiss, P., Portegies, P. (2011) HIV-1 infection and cognitive impairment in the cART era: a review. AIDS 25, 561-575.
190. Desrosiers, R. C., Daniel, M. D., Li, Y. (1989) HIV-related lentiviruses of nonhuman primates. AIDS Res. Hum. Retrovir. 5, 465-473.
191. Murray, E., Rausch, D. M., Lendvay, J., Sharer, L. R., Eiden, L. E. (1992) Cognitive and motor impairments associated with SIV infection in rhesus monkeys. Science 255, 1246-1249.
192. Zink, M. C., Spelman, J. P., Robinson, R. B., Clements, J. E. (1998) SIV infection of macaques-modeling the progression to AIDS dementia. J. Neurovirol. 4, 249-259.
193. Apetrei, C., Robertson, D. L., Marx, P. A. (2004) The history of SIVS and AIDS: epidemiology, phylogeny and biology of isolates from naturally SIV infected non-human primates (NHP) in Africa. Front. Biosci. 9, 225-254.
194. Clements, J. E., Anderson, M. G., Zink, M. C., Joag, S. V., Narayan, O. (1994) The SIV model of AIDS encephalopathy. Role of neurotropic viruses in diseases. Res. Publ. Assoc. Res. Nerv. Ment. Dis. 72, 147-157.
195. Lackner, A. A., Vogel, P., Ramos, R. A., Kluge, J. D., Marthas, M. (1994) Early events in tissues during infection with pathogenic (SIVmac239) and nonpathogenic (SIVmac1A11) molecular clones of simian immunodeficiency virus. Am. J. Pathol. 145, 428-439.
196. Mankowski, J. L., Spelman, J. P., Ressetar, H. G., Strandberg, J. D., Laterra, J., Carter, D. L., Clements, J. E., Zink, M. C. (1994) Neurovirulent simian immunodeficiency virus replicates productively in endothelial cells of the central nervous system in vivo and in vitro. J. Virol. 68, 8202-8208.
197. Fox, H. S., Gold, L. H., Henriksen, S. J., Bloom, F. E. (1997) Simian immunodeficiency virus: a model for NeuroAIDS. Neurobiol. Dis. 4, 265-274.
198. Williams, K. C., Corey, S., Westmoreland, S., Pauley, D., Knight, H., de-Bakker, C., Alvarez, X., Lackner, A. A. (2001) Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS. J. Exp. Med. 193, 905-916.
199. Zink, M. C., Clements, J. E. (2002) A novel simian immunodeficiency virus model that provides insight into mechanisms of human immunodeficiency virus central nervous system disease. J. Neurovirol. 8 (Suppl. 2), 42-48.
200. Schmitz, J. E., Kuroda, M. J., Santra, S., Sasseville, V. G., Simon, M. A., Lifton, M. A., Racz, P., Tenner-Racz, K., Dalesandro, M., Scallon, B. J., Ghrayeb, J., Forman, M. A., Montefiori, D. C., Rieber, E. P., Letvin, N. L., Reimann, K. A. (1999) Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 283, 857-860.
201. Zink, M. C., Coleman, G. D., Mankowski, J. L., Adams, R. J., Tarwater, P. M., Fox, K., Clements, J. E. (2001) Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis. J. Infect. Dis. 184, 1015-1021.
202. Otani, I., Akari, H., Nam, K.-H., Mori, K., Suzuki, E., Shibata, H., Doi, K., Terao, K., Yosikawa, Y. (1998) Phenotypic changes in peripheral blood monocytes of cynomolgus monkeys acutely infected with simian immunodeficiency virus. AIDS Res. Human Retrovir. 14, 1181-1186.
203. Kuwata, T., Kodama, M., Sato, A., Suzuki, H., Miyazaki, Y., Miura, T., Hayami, M. (2007) Contribution of monocytes to viral replication in macaques during acute infection with simian immunodeficiency virus. AIDS Res. Human Retrovir. 23, 372-380.
204. Clements, J. E., Gama, L., Bullock, B., Carruth, L. M., Mankowski, J. L., Zink, M. C. (2005) The central nervous system is a viral reservoir in simian immunodeficiency virus-infected macaques on combined antiretroviral therapy: a model for human immunodeficiency virus patients on highly active antiretroviral theraby. J. Neurovirol. 11, 180-189.
205. Hasegawa, A., Liu, H., Ling, B., Borda, J. T., Alvarez, X., Sugimoto, C., Vinet-Oliphant, H., Kim, W.-K., Williams, K. C., Ribeiro, R. M., Lackner, A. A., Veazey, R. S., Kuroda, M. J. (2009) The level of monocyte turnover predicts disease progression in the macaque model of AIDS. Blood 114, 2917-2925.
206. Williams, K., Westmoreland, S., Greco, J., Ratai, E., Lentz, M., Kim, W. K., Fuller, R. A., Kim, J. P., Autissier, P., Sehgal, P. K., Schinazi, R. F., Bischofberger, N., Piatak, M., Lifson, J. D., Masliah, E., Gonzalez, R. G. (2005) Magnetic resonance spectroscopy reveals that activated monocytes contribute to neuronal injury in SIV neuroAIDS. J. Clin. Invest. 115, 2534-2545.
207. Follstaedt, S., Barber, S., Zink, M. (2008) Mechanisms of minocyclineinduced suppression of simian immunodeficiency virus encephalitis: inhibition of apoptosis signal-regulating kinase 1. J. Neurovirol. 14, 376-388.
208. Zink, M. C., Uhrlaub, J., DeWitt, J., Voelker, T., Bullock, B., Mankowski, J., Tarwater, P., Clements, J., Barber, S. (2005) Neuroprotective and anti-human immunodeficiency virus activity of minocycline. JAMA 293, 2003-2011.
209. Witwer, K. W., Gama, L., Li, M., Bartizal, C. M., Queen, S. E., Varrone, J. J., Brice, A. K., Graham, D. R., Tarwater, P. M., Mankowski, J. L., Zink, M. C., Clements, J. E. (2009) Coordinated regulation of SIV replication and immune responses in the CNS. PLoS One 4, e8129.